EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Investigating the safety profiles of exogenous melatonin and associated adverse events: A pharmacovigilance study using WHO‐VigiBase

Untersuchung des Sicherheitsprofils von exogenem Melatonin und assoziierten unerwünschten Ereignissen: pharmakovigilanzielle Studie mit WHO-VigiBase

Minyoung Ha, Dongwon Yoon, Chae-Young Lee, Mose Lee, Young-Wook Kim, Jung-Min Lee, Ju-Young Shin

Journal of Pineal Research · 2024-03 · 76 (2)

DOI: 10.1111/jpi.12949 ↗

Auf einen Blick

In VigiBase wurden zu Melatonin 35 479 Berichte zu unerwünschten Ereignissen ausgewertet. Es zeigten sich mehrere potenzielle Sicherheitssignale, darunter Stürze, Albträume und ungewöhnliche Träume.

Fragestellung

Welche Muster unerwünschter Ereignisse treten nach Melatonin-Gabe auf, und welche Sicherheitssignale sind mit Melatonin assoziiert?

Methode

Retrospektive, beobachtende Pharmakovigilanzstudie mit VigiBase; Vergleich von Melatonin mit allen anderen Arzneimitteln und mit anderen Schlafmedikamenten; Januar 1996 bis September 2022.

Ergebnisse

35 479 Berichte zu unerwünschten Ereignissen. Häufige Sicherheitssignale: tic, educational problems, disturbance in social behavior, body temperature fluctuation und growth retardation. AESIs: accidents and injuries, fall, nightmare und abnormal dreams.

Schlussfolgerung der Autor:innen

Exogenes Melatonin zeigte ein Sicherheitsprofil, das mit anderen Schlafmedikamenten vergleichbar war. Es wurden jedoch mehrere unerwartete potenzielle Sicherheitssignale identifiziert, die weitere Untersuchung erfordern.

Kernaussagen

  • 35 479 Melatonin-assoziierte Berichte zu unerwünschten Ereignissen
  • Sicherheitssignale u. a. für Sturz, Albtraum und abnormal dreams
  • Vergleich mit anderen Schlafmedikamenten zeigte vergleichbares Sicherheitsprofil

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Pineal Research, online erschienen am 25.03.2024. Verfasst von Minyoung Ha und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Sungkyunkwan University, Suwon, South Korea. Hauptthemen laut MEDLINE: Melatonin, Pharmacovigilance. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melatonin, a pineal hormone that modulates circadian rhythms, sleep, and neurotransmitters, is widely used to treat sleep disorders. However, there are limited studies on the safety of melatonin. Therefore, we aimed to present the overall patterns of adverse events (AEs) following melatonin administration and identify potential safety signals associated with melatonin. Using VigiBase, a global individual case safety report (ICSRs) database managed by the World Health Organization (WHO), we conducted a retrospective, observational, pharmacovigilance study of melatonin between January 1996 and September 2022. Disproportionality analysis was conducted using two comparator settings: all other drugs and other sleep medications. We used multivariable logistic regression to estimate reporting odds ratios (RORs) with 95% confidence intervals (CIs) to compare the frequencies of AEs reporting between melatonin and each comparator setting. Furthermore, we assessed adverse events of special interests (AESIs) that could potentially be associated with melatonin. Signals were identified when the following criteria were met: cases ≥3, x 2 ≥ 4, IC025 ≥ 0, and the lower end of the 95% CI of ROR > 2. These signals were then compared with the AE information on the drug labels provided by regulatory bodies. A total of 35 479 AE reports associated with melatonin were identified, with a higher proportion of reports from females (57.1%) and individuals aged 45–64 years (20.8%). We identified 21 AEs that were commonly detected as safety signals in the disproportionality analyses, including tic, educational problems, disturbance in social behavior, body temperature fluctuation, and growth retardation. In AESI analyses, accidents and injuries (adjusted ROR 2.97; 95% CI, 2.80–3.16), fall (2.24; 2.12–2.37), nightmare (4.90; 4.37–5.49), and abnormal dreams (3.68; 3.19–4.25) were detected as a signal of melatonin when compared to all other drugs, whereas those signals were not detected when compared to other sleep medications. In this pharmacovigilance study, exogenous melatonin showed safety profiles comparable to other sleep medications. However, several unexpected potential safety signals were identified, underscoring the need for further investigation at the population level.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelatoninPharmacovigilanceFemaleHumansAdverse Drug Reaction Reporting SystemsRetrospective StudiesWorld Health Organization

Stichwörter der Autor:innen

Adverse event (AE)Adverse event of special interest (AESI)VigiBasemelatoninpharmacovigilance studysignal detectionsleep disorder

Substanzen

Melatonin

Autor:innen und Institutionen

  • School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.
  • Regional Pharmacovigilance Center, Korean Pharmaceutical Association, Seoul, Republic of Korea.
  • Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea.

Zitieren

APA

Ha, M., Yoon, D., Lee, C. Y., Lee, M., Kim, Y. W., Lee, J. M., & Shin, J. Y. (2024). Investigating the safety profiles of exogenous melatonin and associated adverse events: A pharmacovigilance study using WHO‐VigiBase. Journal of Pineal Research, 76(2). https://doi.org/10.1111/jpi.12949

Vancouver

Ha M, Yoon D, Lee CY, Lee M, Kim YW, Lee JM, et al. Investigating the safety profiles of exogenous melatonin and associated adverse events: A pharmacovigilance study using WHO‐VigiBase. Journal of Pineal Research. 2024;76(2). doi:10.1111/jpi.12949

BibTeX
@article{Ha2024,
  author = {Ha, Minyoung and Yoon, Dongwon and Lee, Chae-Young and Lee, Mose and Kim, Young-Wook and Lee, Jung-Min and Shin, Ju-Young},
  title = {Investigating the safety profiles of exogenous melatonin and associated adverse events: A pharmacovigilance study using WHO‐VigiBase},
  journal = {Journal of Pineal Research},
  year = {2024},
  volume = {76},
  number = {2},
  doi = {10.1111/jpi.12949}
}
Kostenlos starten →